Skip to main content
OpenTrials

Clinical trial condition

BRAF V600E

Explore clinical trials studying BRAF V600E. Study availability and eligibility vary by location and protocol.

8 public trials 4 recruiting studies

BRAF V600E trial results

Conditions
Acquired Resistance to KRAS G12C Inhibitor, BRAF, BRAF Gene Mutation, +61 more
Locations
  • Banner Health- MD Anderson Cancer Center Gilbert, Arizona, United States
  • The Angeles clinic - A cedars SINAI AFFILIATE Los Angeles, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • University of California, San Francisco (UCSF) San Francisco, California, United States
View all 27 locations
Conditions
BRAF V600E, Brain Diseases, Central Nervous System Diseases, +25 more
Locations
  • Peking union medical college hospital Beijing, Beijing Municipality, China
  • Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
  • West China Hospital Sichuan University Chengdu, Sichuan, China
  • Tianjin Medical University Cancer Institute and Hospital Tianjin, Tianjin Municipality, China
Conditions
BRAF V600E, Colonic Diseases, Colorectal Neoplasms, +10 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Peking Union Medical College Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Fujian Medical University - Fujian Provincial Cancer Hospital Fuzhou, Fujian, China
  • The First Affiliated Hospital of Xiamen University Xiamen, Fujian, China
View all 34 locations

NCT04526782

Conditions
BRAF V600E, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • Annemasse - CH Ambilly, France
  • Angers - CHU Angers, France
  • Avignon - Institut Sainte-Catherine Avignon, France
  • Bordeaux - Institut Bergonié Bordeaux, France
View all 36 locations